- Home
- TALKW vs CADL Comparison
TALKW vs CADL Comparison
Compare TALKW & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALKW
- CADL
- Stock Information
- Founded
- TALKW 2012
- CADL 1999
- Country
- TALKW United States
- CADL United States
- Employees
- TALKW 521
- CADL N/A
- Industry
- TALKW Medical/Nursing Services
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- TALKW Health Care
- CADL Health Care
- Exchange
- TALKW Nasdaq
- CADL Nasdaq
- Market Cap
- TALKW N/A
- CADL 250.0M
- IPO Year
- TALKW N/A
- CADL 2021
- Fundamental
- Price
- TALKW $0.06
- CADL $6.75
- Analyst Decision
- TALKW
- CADL Strong Buy
- Analyst Count
- TALKW 0
- CADL 5
- Target Price
- TALKW N/A
- CADL $21.40
- AVG Volume (30 Days)
- TALKW 64.2K
- CADL 1.1M
- Earning Date
- TALKW 02-20-2025
- CADL 08-12-2025
- Dividend Yield
- TALKW N/A
- CADL N/A
- EPS Growth
- TALKW N/A
- CADL N/A
- EPS
- TALKW N/A
- CADL N/A
- Revenue
- TALKW $181,291,000.00
- CADL N/A
- Revenue This Year
- TALKW N/A
- CADL N/A
- Revenue Next Year
- TALKW N/A
- CADL N/A
- P/E Ratio
- TALKW N/A
- CADL N/A
- Revenue Growth
- TALKW 31.50
- CADL N/A
- 52 Week Low
- TALKW $0.20
- CADL $3.79
- 52 Week High
- TALKW $0.24
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- TALKW N/A
- CADL 67.45
- Support Level
- TALKW N/A
- CADL $5.78
- Resistance Level
- TALKW N/A
- CADL $7.25
- Average True Range (ATR)
- TALKW 0.00
- CADL 0.41
- MACD
- TALKW 0.00
- CADL 0.19
- Stochastic Oscillator
- TALKW 0.00
- CADL 82.94
About TALKW Talkspace Inc. Warrant
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.